WFG Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AL
WFG Advisors's DGX Position: Q2 2017 in Review
WFG Advisors increased its Quest Diagnostics (DGX) stake by 45% in Q2 2017, buying an estimated $31.8K and bringing the position to 966 shares worth $107K. The position accounts for 0.02% of the portfolio, ranked #513.
WFG Advisors first reported a position in DGX in Q2 2013 and has held it in 16 quarters since. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.
- WFG Advisors held 966 shares of Quest Diagnostics worth $107K as of Q2 2017.
- WFG Advisors bought 301 Quest Diagnostics shares in Q2 2017, an estimated $31.8K.
- Quest Diagnostics made up 0.02% of WFG Advisors's portfolio in Q2 2017, its #513 holding.
- WFG Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 16 quarters since.
- 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.
Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.